Kymera Therapeutics KYMR Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's total debt?
- Kymera Therapeutics (KYMR) reported total debt of $82.17M in Q1 2026.
- How has Kymera Therapeutics's total debt changed year-over-year?
- Kymera Therapeutics's total debt decreased by 6.5% year-over-year, from $87.89M to $82.17M.
- What is the long-term trend for Kymera Therapeutics's total debt?
- Over 5 years (2020 to 2025), Kymera Therapeutics's total debt has grown at a 35.1% compound annual growth rate (CAGR), from $18.68M to $84.07M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.